2005
DOI: 10.1007/s11239-005-1849-9
|View full text |Cite
|
Sign up to set email alerts
|

Transitioning from Argatroban to Warfarin in Heparin-Induced Thrombocytopenia: An Analysis of Outcomes in Patients with Elevated International Normalized Ratio (INR)

Abstract: In patients receiving argatroban/warfarin cotherapy and with an elevated INR > 4, the risk for thrombosis exceeds the risk of bleeding. Traditional paradigms concerning elevated INRs and warfarin may need to be redesigned for the patient population on cotherapy with direct thrombin inhibitors.Abbreviated Abstract. The clinical outcomes of 111 patients with INRs > 4 while on combined argatroban (dose < or = 2 mcg/kg/min) and warfarin were evaluated. Adverse clinical outcomes (7 new thrombosis, 3 amputations, 12… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
36
0
2

Year Published

2005
2005
2020
2020

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(38 citation statements)
references
References 24 publications
0
36
0
2
Order By: Relevance
“…3.0 while receiving argatroban and warfarin cotherapy had a subtherapeutic INR 4 h after discontinuation of argatroban. 116 The INR should not be interpreted as an indicator of the effect of warfarin alone when administered with argatroban.…”
Section: Discontinuing Thrombin Inhibitor After a Minimum Of 5 Days Omentioning
confidence: 99%
“…3.0 while receiving argatroban and warfarin cotherapy had a subtherapeutic INR 4 h after discontinuation of argatroban. 116 The INR should not be interpreted as an indicator of the effect of warfarin alone when administered with argatroban.…”
Section: Discontinuing Thrombin Inhibitor After a Minimum Of 5 Days Omentioning
confidence: 99%
“…112,113 The VKAs should be initiated when platelet counts have normalized to a steady state, then brought on underbridged with a DTI. [114][115][116] There is emerging evidence that the newly developed small molecule anticoagulants including apixaban, dabigatran, edoxaban, otamixaban, and rivaroxaban may become new immediate and long-term treatment options for thrombosis in patients with HIT. 109 …”
Section: -109mentioning
confidence: 99%
“…Therefore, the previously established relationship between INR and bleeding risk is altered. As opposed to the usual practice, argatroban should be only discontinued, when an INR > 4 is reached [139,140]. The theoretical INR values on VKA alone can be calculated by means of the measured INR using adequate algorithms [139,137].…”
Section: Effect On International Normalized Ratio (Inr)mentioning
confidence: 99%